About Astorion Pharma
Astorion Pharma is a Healthcare company based in Hyderabad (India) founded in 2011. Pharmaceutical company specializing in diabetes and related health products in India. The company has 6 employees. Its Indian entity Astorion Pharmaceuticals Private Limited reported revenue of ₹1.87 Cr. Astorion Pharma offers products and services including Diabetes Products and Anti Cholesterol Tablets. Its focus areas include Pharmaceuticals, Diabetes Management, Anti-diabetic Drugs and Nutraceuticals.
Company details
Astorion Pharma is recognized for its commitment to addressing diabetes through the development of high-quality medicines that target chronic conditions such as diabetes, hypertension, and heart failure. Various segments in anti-diabetic drugs have been entered to provide effective treatments, with operations conducted in the domestic market via a dedicated team. Innovation is pursued through collaborations among scientists, doctors, and patients to meet market needs, while quality procedures are globalized and harmonized for sustainability. The company operates with a focus on growth and regulatory compliance, offering products across India.
- Headquarters Hyderabad, India
- Employees 6
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn Facebook
- Legal Name Astorion Pharmaceuticals Pvt Ltd
- Date of Incorporation 12 Aug, 2011
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1.87 Cr
FY 2025 · +16% YoY
- Net Profit₹3.6 Lakh
FY 2025 · 2% margin
- EBITDA₹22.9 Lakh
FY 2025 · 12% margin
- Employee Count6
Associated legal entities of Astorion Pharma
Astorion Pharma operates through Astorion Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Astorion Pharmaceuticals Private Limited CIN U24232TG2011PTC075940 | Active | 12 Aug 2011 | Hyderabad, Telangana | ₹1.9 Cr | 6 | 2 | View details |
Products & Services of Astorion Pharma
Astorion Pharma offers a comprehensive portfolio of products and services, including Diabetes Products and Anti Cholesterol Tablets.
Products for managing diabetes and related complications are developed and distributed for treating chronic diseases.
Tablets for controlling cholesterol levels are offered as part of efforts to address associated health risks.
Board of directors of Astorion Pharmaceuticals Private Limited (Astorion Pharma)
Astorion Pharmaceuticals Private Limited is the primary company behind Astorion Pharma. The board of Astorion Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Koyalkar Arun Kumar, appointed in 2011.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Koyalkar Arun Kumar DIN 03585537 | Director | 12 Aug 2011 | 15 yrs 2 mo | Astorion Pharmaceuticals Private Limited |
| Koyelkar Jyoshna DIN 03585602 | Director | 12 Aug 2011 | 15 yrs 2 mo | Astorion Pharmaceuticals Private Limited |
Financials of Astorion Pharma
Figures of Astorion Pharmaceuticals Private Limited, the primary company behind Astorion Pharma, for FY 2025. Revenue was ₹1.87 Cr (+16% year on year). Net profit was ₹3.6 Lakh (2% margin). EBITDA was ₹22.9 Lakh (12% margin). Revenue has grown at a compounded annual rate of +24% over three years and +13% over five years.
- ₹1.87 CrRevenue · FY 2025 · +16% YoY
- ₹3.6 LakhNet profit · 2% margin
- ₹22.9 LakhEBITDA · 12% margin
- ₹1 LakhPaid-up capital
- 6Employees (provident fund records)
- +24%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Astorion Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Astorion Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Astorion Pharma
Astorion Pharma was founded in 2011.
Astorion Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Astorion Pharma has 6 employees.
The primary company behind Astorion Pharma, Astorion Pharmaceuticals Private Limited, reported revenue of ₹1.87 Cr for FY 2025, up 16% year on year.
Astorion Pharma is recognized for its commitment to addressing diabetes through the development of high-quality medicines that target chronic conditions such as diabetes, hypertension, and heart failure. Various segments in anti-diabetic drugs have been entered to provide effective treatments, with operations conducted in the domestic market via a dedicated team. Innovation is pursued through collaborations among scientists, doctors, and patients to meet market needs, while quality procedures are globalized and harmonized for sustainability. The company operates with a focus on growth and regulatory compliance, offering products across India.
Astorion Pharma offers Diabetes Products and Anti Cholesterol Tablets.
Astorion Pharma operates through Astorion Pharmaceuticals Private Limited.
The legal entities of Astorion Pharma currently have 2 directors, including Koyalkar Arun Kumar, Koyelkar Jyoshna.